Does the cytokine adsorber CytoSorb® reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study

Abstract Background Hemadsorption of cytokines is used in critically ill patients with sepsis or septic shock. Concerns have been raised that the cytokine adsorber CytoSorb® unintentionally adsorbs vancomycin. This study aimed to quantify vancomycin elimination by CytoSorb®. Methods Critically ill p...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Christina Scharf, Ferdinand Weinelt, Ines Schroeder, Michael Paal, Michael Weigand, Michael Zoller, Michael Irlbeck, Charlotte Kloft, Josef Briegel, Uwe Liebchen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2022-05-01
coleção:	Annals of Intensive Care
Assuntos:	Vancomycin Critically ill patients CytoSorb® Sepsis Pharmacokinetics Adsorption
Acesso em linha:	https://doi.org/10.1186/s13613-022-01017-5
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!